There was very little movement this week. The only big loser was TEK:Tekcapital which dropped 6% to go down to the placing price that was announced this week. I should have learnt my lesson with ALM:Allied Minds and avoided IP companies, as the inventions they invest in are rarely going to make a profit.
IQE:IQE has been making steady progress but is still a long way behind the companies it supplies. I think the market needs some convincing that they are capable of making a profit even when sales are good. I'm down 27% in my ISA, 50% in my trading account, and a horrible 59% in my SIPP. It's locked up £5,049 which I suspect will be trapped for some time yet. No share in my portfolio has fallen from grace quite so badly. I did however make £12,000 profit trading it during the shorting wars, so I have a lot to thank it for and can accept having a bit of that profit trapped for a few years.
Share of the Week is IKA:Ilika, which has been super volatile lately. It's a shame all the companies I own that are nearly back in the black seem to have a resistance point just below where I bought them, so I never seem to get into profit. I need another 9% for these to start earning money.
In the right direction, but it looked so much better on Tuesday evening.
Time to reverse that trend. I'd like to see a new line running from week 213 and heading upwards into profit.Just a matter of the 6 month wait for that to possibly happen.
The ISA and share accounts look like this
| Weekly Change | |||
| Cash | £13.44 | +£1.45 | |
| Portfolio cost | £57,783.58 | -£5.20 | |
| Portfolio sell value (bid price-commission) | £44,097.24 | (-23.7%) | +£637.59 |
| Potential profits | £0 | +£0 | |
| Yr 5 Dividends | £0.63 | +£0 | |
| Yr 5 Profit from sales | £-167.28 | +£0 | |
| Yr 5 Average monthly cash profit | -£30.36 | (-0.6%) | +£0.54 |
| Total Dividends | £1,342.93 | +£0 | |
| Total Profit from sales | £20,224.13 | +£0 | |
| Average monthly cash profit | £393.74 | (8.2%) | -£1.75 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Performance/Injection | 12.7% | +0% | |
| Compound performance | 57% | +0% |
I didn't get my requested allocation of MAIS:Maistro shares in the open offer, so returned £5.20 to the account, but £3.75 ISA charge came out of that. The portfolio value went up £637, but still nothing in profit. OPTI:Optibiotix is only 6% down after a 1p rise, IKA:Ilika is only 9% down and JLP:Jubilee Metals is only 16% down and looking ready for a re-rate, so I'm hopeful there will be something in profit soon.
Still way too close to the orange line
If OPTI:Optibiotix can get to 100p this will be back in the black. It's got 3 weeks until I lose my last positive submission and we have a whole year in the red.
Here's the SIPP after week 219
| Weekly Change | ||||
| Cash | £59.40 | -£15.35 | ||
| Portfolio cost | £46,995.31 | +£0 | ||
| Portfolio sell value (bid price - commission) |
£40,103.78 | (-14.7%) | +£789.16 | |
| Potential profits | £392.97 | +£225.00 | ||
| Yr 5 Dividends | £0 | +£0 | ||
| Yr 5 Interest | £0.02 | +£0 | ||
| Yr 5 Profit from sales | £0 | +£0 | ||
| Yr 5 Average monthly cash profit | -£17.30 | (-0.4%) | -£4.92 | |
| Total Dividends | £1,899.24 | +£0 | ||
| Total Interest | £0.18 | +£0 | ||
| Total Profit from sales | £12,549.10 | +£0 | ||
| Average monthly cash profit | £276.25 | (7.1%) | -£1.57 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Performance/Injection | 11.1% | -0.01% | ||
| Compound performance | 47% | +0% |
Cash went down due to monthly fees. A bigger rise here than the ISA as CAML:Central Asia Metals went up a few percent on top of the OPTI:Optibiotix rise, so potential profits also went up as CAML is my only share in the black.
I should probably start to worry that my average monthly performance will soon slip below 7%. There's only MMX:minds + Machines and SBTX:SkinBioTherapeutics that can possibly help resolve this, as the others are either long term holdings or completely useless. However it's going to take quite a big profit in either of those to give me an average of 3% over 4 years. I'll need well over £1,000 which is 100% for MMX and 50% for SBTX. That's not going to happen any time soon.
What makes things worse it that I get my next injection of £2,000 next month, which will lower the performance percentage even more. I guess I could just focus on the performance based on injection, which is 11% so above target, but I set the target based on portfolio cost, so should really stick to that. In summary, I need to sell something soon with a big profit.
I'm about to hit the point where the value has crashed back down 3 times now. I really hope that doesn't happen again.
I'm the right side of the line so should be moderately happy.
Here's the trading account after week 185
| Weekly Change | |||
| Cash | £48.24 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,323.67 | (-43.0%) | +£5.01 |
| Potential profits | £0 | +£0 | |
| Year 4 Dividends | £13.20 | +£0 | |
| Year 4 Profit | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £1.97 | (1.0%) | -£0.07 |
| Dividends | £47.92 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.38 | (-0.2%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Performance/Injection | -0.2% | +0% | |
| Compound performance | -1% | +0% |
This account was meant to be fun, but it's not. Rises in several companies were blatted this week when TEK:Tekcapital went and did a placing. At least it went up a little bit. CAML:Central Asia Metals is only 17% down and the closest to enabling a sale. There's still no sign of TALY:Tally re-listing.
I think we can safely call that a year of inactivity in an account I thought I'd be buying and selling with weekly. The big mistake was buying shares with such a big spread that they were 15% down the second I bought them, or buying some of my favourite shares despite the fact that there was no evidence I was getting them cheap enough to have a likely quick rise.
The one glimmer of hope - we're the right side of the trend line.
Here's the fantasy magic formula account
| Weekly Change | |||
| Cash | £153.61 | +£0 | |
| Portfolio cost | £29,846.39 | +£0 | |
| Portfolio sell value (bid price - commission) | £31,010.02 | (+3.4%) | +£460.48 |
| Potential profits | £1,796.40 | +£150.06 | |
| Year 1 Dividends | £0 | +£0 | |
| Year 1 Profit | £0 | +£0 | |
| Yr 1 Average monthly cash profit | £0 | (0%) | +£0 |
| Dividends | £0 | +£0 | |
| Profit from sales | £0 | +£0 | |
| Average monthly cash profit | £0 | (0%) | +£0 |
| (Sold stocks profit + Dividends - Fees / Months) |
Not a bad week, with value increasing by £460, £150 of which was increased paper profits.
The house builders are still doing best, up around 20%, and the dodgy AIM shares are still doing the worst, down around 14%. Friday was a pretty awful day, with only 3 of the 30 companies increasing in value.
At the moment, this method of picking shares would be doing very well for me, as long as I avoid AIM companies. It's going to be realy difficult next month though, as with CAML:Central Asia Metals still really cheap, and almost in the top 30 anyway, how am I going to resist buying those instead of holding my nerve and starting to build a magic formula portfolio for real?
No comments:
Post a Comment